0001640334-22-001248.txt : 20220615 0001640334-22-001248.hdr.sgml : 20220615 20220614174638 ACCESSION NUMBER: 0001640334-22-001248 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220430 FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220614 EFFECTIVENESS DATE: 20220615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Huaizhong Health Group, Inc. CENTRAL INDEX KEY: 0001593204 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 901020141 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55369 FILM NUMBER: 221015999 BUSINESS ADDRESS: STREET 1: TIANAN TECHNOLOGY PARK, 13/F HEADQUARTER STREET 2: CENTER BUILDING 16, 555 PANYU NORTH AVE CITY: PANYU DISTRICT, GUANGZHOU CITY STATE: F4 ZIP: 00000 BUSINESS PHONE: 86 (20) 2982 9356 MAIL ADDRESS: STREET 1: TIANAN TECHNOLOGY PARK, 13/F HEADQUARTER STREET 2: CENTER BUILDING 16, 555 PANYU NORTH AVE CITY: PANYU DISTRICT, GUANGZHOU CITY STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Adaiah Distribution Inc DATE OF NAME CHANGE: 20131129 NT 10-Q 1 huaizhong_nt10k.htm NT 10-Q huaizhong_nt10k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

Commission File No. 000-55369

 

NOTIFICATION OF LATE FILING

 

(Check One):

☐  Form 10-K

☐  Form 20-F 

☐  Form 11-K

☒  Form 10-Q

☐  Form 10-D

☐  Form N-SAR

☐  Form N-CSR

 

For Period Ended: April 30, 2022

 

Transition Report on Form 10-K

Transition Report on Form 20-F

Transition Report on Form 11-K

Transition Report on Form 10-Q

Transition Report on Form N-SAR

For the Transition Period Ended: __________________

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

  

PART I — REGISTRANT INFORMATION

 

Huaizhong Health Group, Inc.

Full Name of Registrant

 

 

 

Former Name if Applicable

 

Tianan Technology Park

13/F Headquarters Center Building 16

555 Panyu North Ave., Panyu District

Address of Principal Executive Office (Street and Number)

Guangzhou City, China

City, State and Zip Code

 

 

 

  

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report thereof, could not be filed within the prescribed time period.

 

Huaizhong Health Group, Inc. (the “Company”) could not complete the filing of its Quarterly Report on Form 10-Q for the period ended April 30, 2022 due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-Q, which delay could not be eliminated by the Company without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-Q no later than the fifth calendar day following the prescribed due date.

 

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

Yuantong Wang

+86 (20)

2982 9356

(Name)

(Area Code)

(Telephone Number)

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

Yes ☒  No ☐

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes ☐  No ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 
2

 

  

Huaizhong Health Group, Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 14, 2022

By:

/s/ Yuantong Wang

 

Name: Yuantong Wang

 

Title: President

 

 

 
3